Description

Innovative Approaches to Autism Spectrum Disorder

This online course is the only of its kind on Autism Spectrum Disorder (ASD) across the lifespan, and contains innovative guidance to help you overcome clinical challenges and provide optimal care to your often complex patients with ASD. Course sessions include short-format lectures and round table discussions with renowned experts and focus on multidisciplinary collaboration and treatment strategies, as well as diagnostic dilemmas, assessment measures, neuroimaging, evidence-based psychopharmacology, legal issues, psychiatric comorbidities, genetics, behavioral interventions, and more.

Faculty in this course represent a “Who’s Who” of national experts in the field of ASD from Massachusetts General Hospital, MassGeneral Hospital for Children, Harvard Medical School, Yale University, University of California Los Angeles, Cincinnati Children’s Hospital, Massachusetts Institute of Technology, and others. Sessions are in full HD video, are 100% tablet- and mobile-friendly, and include hundreds of information-packed slides that are chapterized and scrollable so you can focus on any topics and sections you want.

This course is completely on-demand, so you can participate whenever your practice schedule allows. These lectures were captured at the live "Autism Spectrum Disorders Across the Lifespan" course held on January 11-12, 2014 in Boston, Massachusetts.

CME credit is not being offered for this activity.

What You Learn From This Course

The more than two dozen sessions and faculty experts in this course focus on the assessment and treatment of ASD, as well as many facets of multidisciplinary collaboration. Enhance your clinical knowledge and practice on these key topics:

  • Diagnostic considerations for high-functioning ASD, including an in-depth look at DSM-5 diagnostic criteria, innovative assessment measures and diagnostic tools, and more
  • Psychiatric comorbidities in individuals with ASD, such as ADHD, anxiety, OCD, and bipolar disorder, and corresponding diagnosis and management strategies
  • Cognitive-behavioral therapy, collaborative problem solving, applied behavioral analysis, and other innovative psychosocial approaches to ASD
  • Latest advances in neuroimaging, genetics, and treatment research in ASD
  • Assessing work and driving needs in individuals with ASD
  • Neuropsychological assessment, neuroimaging, and the promise of genetics in clinical practice
  • Social skills training for youth with ASD
  • Distinguishing emotional dysregulation from mood disorders
  • Modularized and targeted treatments on core deficits for children with ASD
  • Legal issues in treating individuals with ASD
  • Psychopharmacologic treatment strategies

Target Audience

This program is intended for: Pediatricians, primary care physicians, nurses, school mental health counselors, social workers, psychologists, psychiatrists, special educators, therapists, and other mental health professionals.

Pricing

Individual Rate: $145.00

Group Rate: $95.00
***If 3 or more clinicians from your institution would benefit from this course, contact us to get our discounted per person group rate. Contact us at mghcme@partners.org for more information.***

Cancellation Policy

Cancellation requests must be made within 10 business days after the initial purchase to receive a refund minus a $25.00 administrative fee. No refunds will be made thereafter.

Topics Covered

This course includes more than two dozen sessions led by renowned faculty across a variety of critical topics, as well as multiple roundtable discussions with expert clinician-researchers addressing clinical challenges and questions on ASD, including:

Assessment Measures
  • Autism Diagnostic Interview-Revised (ADI-R) & Observation Schedule (ADOS): Strengths and Limitations
  • Other Screening Tools for ASD
  • Rapid Ascertainment of Autistic Symptom Severity Using the Social Responsiveness Scale (SRS)
  • Round Table Discussion – Assessment Measures
Diagnostic Dilemmas
  • DSM-V Approach to Autism Spectrum Disorder
  • Round Table Discussion – Diagnostic Dilemmas
Genetics of Autism: Clinical Implications
  • The Autistic Phenotype in Selected Monogenic Syndromes
  • Are Autistic Traits Clinically Meaningful?
  • Assessing Work and Driving Needs in High-Functioning Autism Spectrum Disorder
  • Legal Issues in Treating Individuals with Autism
  • Neuropsychological Assessment of Autism Spectrum Disorder
  • Potential Role of Pharmacogenetics in Autism
  • The Promise of Genetic Research in Autism
  • Round Table Discussion – Genetics of Autism: Clinical Implications
The Promise of Neuroimaging for Clinical Practice
  • Functional Neuroimaging in Autism
  • Spectroscopic Neuroimaging in Autism
  • Structural Neuroimaging in Autism
  • Round Table Discussion – The Promise of Neuroimaging for Clinical Practice
Psychiatric Comorbidity
  • ADHD
  • Anxiety Disorders
  • Bipolar Disorder
  • Distinguishing Emotional Regulation from Mood Disorders
  • Distinguishing Stereotypies from Obsessive Compulsive Disorder
  • Round Table Discussion – Psychiatric Comorbidity
Psychological Interventions
  • Applied Behavioral Analysis (ABA): What Is It, Does It Work, and Who Provides It?
  • Cognitive-Behavior Therapy for Autism Spectrum Disorder
  • Collaborative Problem Solving
  • Modularized and Targeted Treatments on Core Deficits for Children with Autism Spectrum Disorder
  • Social Skills Training for Youth with High-Functioning Autism Spectrum Disorder
  • Round Table Discussion – Psychological Interventions
Psychopharmacologic Interventions
  • The Contribution of RUPPs Toward the Development of Evidence-Based Psychopharmacology
  • New Drug Targets in Autism
  • Pharmacotherapy for Core Features of Autism
  • Round Table Discussion – Psychopharmacologic Interventions

Faculty

  • Director, Think:Kids, Department of Psychiatry, Massachusetts General Hospital
    Director, Psychotherapy Research Program, Massachusetts General Hospital
    Associate Clinical Professor of Psychology in the Department of Psychiatry, Harvard Medical School
  • Director of Research, The New England Center for Children
  • Director of Research, University of California Davis MIND Institute
  • Founding Director, LADDERS
  • Director, Pediatric Psychopharmacology Unit, Massachusetts General Hospital
    Professor of Psychiatry, Harvard Medical School
  • Assistant Professor, Division of Developmental and Behavioral Pediatrics
  • Director, Division of Child Psychiatry, St. Louis Children's Hospital
    Blanche F. Ittleson Professor of Psychiatry and Pediatrics, Washington University School of Medicine
  • Director, Medical Genetics Research, Director, Child and Adolescent Psychiatry Research
    Professor of Psychiatry and Neuroscience and Physiology, SUNY Upstate Medical University
  • Co-Director of Neuropsychology in the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital
    Instructor in Psychology in the Department of Psychiatry, Harvard Medical School
  • Director, Martinos Imaging Center
    Grover Hermann Professor in Health Sciences and Technology and Cognitive Neuroscience, Massachusetts Institute of Technology
  • Co-Director, Child Cognitive-Behavioral Therapy Program, Massachusetts General Hospital
    Director, Cognitive Behavior Therapy Program, Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital
    Assistant Professor of Psychology in the Department of Psychiatry, Harvard Medical School
  • Co-Director, Child Cognitive-Behavioral Therapy Program, Massachusetts General Hospital
    Director of High-Risk Studies and Anxiety Research, Pediatric Psychopharmacology Program, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Director, Autism Spectrum Disorders Program
    Clinical & Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital
    Assistant Professor of Psychiatry, Harvard Medical School
  • Professor of Psychological Studies in Education and Psychiatry, University of California Los Angeles
  • Director, Rett Syndrome Program, Boston Children's Hospital
    Co-Director, Fragile X Syndrome Program, Boston Children's Hospital
    Co-Director, Down Syndrome Program, Boston Children's Hospital
  • Director, Neurostatistics Laboratory, Harvard Medical School
    Associate Professor of Psychiatry and Biostatistics, Harvard Medical School
  • Director, Division of Child and Adolescent Psychiatry, University of California Los Angeles
    Jane & Terry Semel Institute for Neuroscience & Human Behavior, University of California Los Angeles
  • Founding Director, the Lurie Center for Autism, Massachusetts General Hospital and MassGeneral Hospital for Children
    Nancy Lurie Marks Professor in the Field of Autism, Harvard Medical School
  • Executive Director, Aspire
    Clinical Instructor in Psychology, Harvard Medical School
  • Director, Law & Psychiatry Service, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Irving B. Harris Professor of Child Psychiatry, Pediatrics, and Psychology, Yale University School of Medicine
    Director, Child Study Center, Yale University School of Medicine
  • Director, Child and Adolescent Outpatient Department, Massachusetts General Hospital
    Director, Pediatric Bipolar Disorder Clinical and Research Program, Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School

CME Information

Release Date: May 5, 2014
Expiration Date: May 5, 2015

CREDIT 

TYPE

 

ACCREDITATION STATEMENT

 

DESIGNATION STATEMENT

0.00

 

This program is not accredited.

 

 

 

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education. CME credit is not being offered for this activity.

 

 

  

Even though this event is not accredited, providing information regarding planning, disclosure, and conflict of interest is important to us. Some providers may be able to claim Category 2 CME credit for participating in this activity.


Faculty Disclosure Statement

In accord with the guidelines of the Accreditation Council for Continuing Medical Education (ACCME), planners, speakers and anyone who may have an influence on the content of the activity have been asked to disclose any relationship they or their spouse/partner have to companies producing pharmaceuticals, medical equipment, devices, etc. that may be germane to the content of their presentation. Such disclosure is not intended to suggest or condone bias, but provides participants with information that might be of potential importance to their evaluation of a given presentation.

Resolution of Conflict of Interest (COI)

The MGH Academy has implemented a process to resolve potential COIs for this CME activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public.


Planner Disclosures

The following planners and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:

Tristan Gorrindo, MD, Reviewer
Gagan Joshi, MD

The following planners and/or their spouse/partner have reported a relevant financial relationship with a commercial interest:

Joseph Biederman, MD
In 2014, Dr. Biederman received research support from the following sources: Elminda, Janssen, McNeil, Shire Research
201: Dr. Biederman received an honorarium from the MGH Psychiatry Academy and The Children’s Hospital of Southwest Florida/Lee Memorial Health System for tuition-funded CME courses
In 2011, Dr. Biederman gave a single unpaid talk for Juste Pharmaceutical Spain, received honoraria from the MGH Psychiatry Academy for a tuition-funded CME course, and received honoraria for presenting at international scientific conference on ADHD. He also received an honorarium from Cambridge University Press for a chapter publication. He received departmental royalties from a copyrighted rating scale used for ADHD diagnoses, paid by Eli Lilly, Shire and AstraZeneca; these royalties are paid to the Department of Psychiatry at MGH. 
In 2010, Dr. Biederman received a speaker’s fee from a single talk given at Fundación Dr.Manuel Camelo A.C. in Monterrey Mexico. He provided single consultations for Shionogi Pharma Inc. and Cipher Pharmaceuticals Inc.; the honoraria for these consultations were paid to the Department of Psychiatry at the MGH. He received honoraria from the MGH Psychiatry Academy for a tuition-funded CME course.
In previous years, Dr. Joseph Biederman received research support, consultation fees, or speaker’s fees for/from the following additional sources: Abbott, Alza, AstraZeneca, Boston University, Bristol Myers Squibb, Celltech, Cephalon, Eli Lilly and Co., Esai, Fundacion Areces (Spain), Forest, Glaxo, Gliatech, Hastings Center, Janssen, McNeil, Medice Pharmaceuticals (Germany), Merck, MMC Pediatric, NARSAD, NIDA, New River, NICHD, NIMH, Novartis, Noven, Neurosearch, Organon, Otsuka, Pfizer, Pharmacia, Phase V Communications, Physicians Academy, The Prechter Foundation, Quantia Communications, Reed Exhibitions, Shire, the Spanish Child Psychiatry Association, The Stanley Foundation, UCB Pharma Inc., Veritas, and Wyeth.


Speaker Disclosures

The following speakers and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:

J. Stuart Ablon, PhD
William Ahearn, PhD, BCBA-D
David Amaral, PhD
Margaret Bauman, MD
Stephen Faraone, PhD
Ronna Fried, EdD
John Gabrieli, PhD
Dina Hirshfeld-Becker, PhD
Connie Kasari, PhD
Nicholas Lange, ScD
Christopher McDougle, MD
Scott McLeod, PhD
Ronald Schouten, MD, JD
Dennis Wall, PhD
Brian Willoughby, PhD

The following speakers and/or their spouse/partner have reported a relevant financial relationship with a commercial interest:

Joseph Biederman, MD 
In 2014, Dr. Biederman received research support from the following sources: Elminda, Janssen, McNeil, Shire Research
201: Dr. Biederman received an honorarium from the MGH Psychiatry Academy and The Children’s Hospital of Southwest Florida/Lee Memorial Health System for tuition-funded CME courses
In 2011, Dr. Biederman gave a single unpaid talk for Juste Pharmaceutical Spain, received honoraria from the MGH Psychiatry Academy for a tuition-funded CME course, and received honoraria for presenting at international scientific conference on ADHD. He also received an honorarium from Cambridge University Press for a chapter publication. He received departmental royalties from a copyrighted rating scale used for ADHD diagnoses, paid by Eli Lilly, Shire and AstraZeneca; these royalties are paid to the Department of Psychiatry at MGH. 
In 2010, Dr. Biederman received a speaker’s fee from a single talk given at Fundación Dr.Manuel Camelo A.C. in Monterrey Mexico. He provided single consultations for Shionogi Pharma Inc. and Cipher Pharmaceuticals Inc.; the honoraria for these consultations were paid to the Department of Psychiatry at the MGH. He received honoraria from the MGH Psychiatry Academy for a tuition-funded CME course. 
In previous years, Dr. Joseph Biederman received research support, consultation fees, or speaker’s fees for/from the following additional sources: Abbott, Alza, AstraZeneca, Boston University, Bristol Myers Squibb, Celltech, Cephalon, Eli Lilly and Co., Esai, Fundacion Areces (Spain), Forest, Glaxo, Gliatech, Hastings Center, Janssen, McNeil, Medice Pharmaceuticals (Germany), Merck, MMC Pediatric, NARSAD, NIDA, New River, NICHD, NIMH, Novartis, Noven, Neurosearch, Organon, Otsuka, Pfizer, Pharmacia, Phase V Communications, Physicians Academy, The Prechter Foundation, Quantia Communications, Reed Exhibitions, Shire, the Spanish Child Psychiatry Association, The Stanley Foundation, UCB Pharma Inc., Veritas, and Wyeth.

Somer L. Bishop, PhD
Royalties: Western Psychological Services

John Constantino, MD
Royalties: Western Psychological Services
Research Support: NICHD, U.S. Centers for Disease Control, U.S. Administration for Children and Families, Autism Speaks

Aude Henin, PhD
Consultant: Pfizer, Otsuka, Prophase, Inc.
Royalties: Oxford University Press

Gagan Joshi, MD
Research Support: Forest Research Institute (2011-2013): Site PI for multi-centered trial

Walter Kaufmann, MD
Consultant: Genentech, Roche
Research Support: Ipsen to Boston Children's Hospital's Rett Syndrome Program, Novartis to Boston Children's Hospital's Fragile X Syndrome Program

James McCracken, MD
Consultant: Roche, BioMarin
Research Grants: Roche, Seaside Therapeutics
Advisory Board: Roche

Fred Volkmar, MD
Publishers: Springer, Wiley, Guilford Press, Wolters-Kluwer

Janet Wozniak, MD
Research Funding: Merck, Shire
Books, Intellectual Property: Bantam Books


Hardware/Software Specifications

This internet-based activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements

Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit


Privacy Policy:

Please click here to review our privacy policy.